Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

XLV vs XLI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

XLV Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

XLV Overall Winner 6-Pillar Tally: XLV 0 – 0 XLI (6 Tie) Matrix Metrics: XLV 2 – 1 XLI

As of Nov 16, 2026, Health Care Select Sector SPDR Fund (XLV) is the stronger overall head-to-head candidate over Industrial Select Sector SPDR Fund (XLI) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). XLV carries a Unified Composite Score of 38.4/100 (SELL) at $188.14 (N/M Forward P/E, N/A operating margin), whereas XLI carries 44.4/100 (HOLD) at $165.70 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While XLI currently prints a higher short-term Unified Composite Score (44.4/100 HOLD vs. XLV 38.4/100 SELL), XLV captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
  • Technical & Structure Timing Caution: XLV trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 67.6); meanwhile XLI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About XLV vs XLI
XLV NYSE Arca Head-to-Head Winner
Health Care Select Sector SPDR Fund
Institutional Equity
$188.14
-0.38% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.26β · 20% Vol
Unified Composite Score
38.4 / 100 SELL
Tech 26.0 Fund 33.0 Flow 50.0 Mom 21.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (3.1% over 20 days), RSI 68
RSI-14: 67.6 · SMA20: $184.33 · SMA50: $175.40
XLI NYSE Arca
Industrial Select Sector SPDR Fund
Institutional Equity
$165.70
-1.82% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.95β · 25% Vol
Unified Composite Score
44.4 / 100 HOLD
Tech 48.0 Fund 53.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.9%) with fading momentum, RSI 47
RSI-14: 46.6 · SMA20: $167.83 · SMA50: $168.79

6-Pillar Scorecard Institutional Category Breakdown (XLV 0 – 0 XLI)

Columns: Metric · XLV · XLI
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 13.0% (1st %ile) 14.2% (48th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Distribution
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: XLV (2) vs XLI (1)
Institutional Metric XLV XLI Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
92% ($142–$192) 45% ($147–$188) Stronger Trend XLV
Beta / 30D Volatility
Risk Regime
0.26β · 20% Vol 0.95β · 25% Vol Lower Realized Risk XLV
Unified Institutional Score
Composite Signal
38.4 / 100 (SELL) 44.4 / 100 (HOLD) Higher Composite XLI
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon XLV +7.7 pp
XLV: +6.47% · XLI: -1.23%
3M Horizon XLV +20.58 pp
XLV: +10.85% · XLI: -9.73%
6M Horizon XLV +32.07 pp
XLV: +29.11% · XLI: -2.96%
1Y Horizon XLV +14.17 pp
XLV: +23.18% · XLI: +9.01%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XLV vs XLI. Trailing 12-month operating profitability (XLV N/A vs XLI N/A) and valuation multiples (XLV N/M vs XLI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

XLV ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
XLI ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
XLV UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 13.0%
IV Percentile 1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XLV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
XLI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 14.2%
IV Percentile 48th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XLI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
XLV Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
XLI Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ XLV vs XLI Key Questions & Quantitative Answers

As of Nov 16, 2026, Health Care Select Sector SPDR Fund (XLV) is the stronger overall head-to-head candidate over Industrial Select Sector SPDR Fund (XLI) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). XLV carries a Unified Composite Score of 38.4/100 (SELL) at $188.14 (N/M Forward P/E, N/A operating margin), whereas XLI carries 44.4/100 (HOLD) at $165.70 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While XLI currently prints a higher short-term Unified Composite Score (44.4/100 HOLD vs. XLV 38.4/100 SELL), XLV captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: XLV trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 67.6); meanwhile XLI is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

XLV and XLI split Growth & Scale metrics: XLV posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with XLI at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, XLV generates N/A in USD-normalized revenue versus N/A for XLI. In operating R&D and SG&A reinvestment, XLV deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for XLI.

XLV and XLI trade at balanced relative valuation multiples. XLV trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas XLI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against XLV (N/A ROE) versus XLI (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, XLV carries 13.0% implied volatility (1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.26β · 20% Vol realized risk). By comparison, XLI carries 14.2% implied volatility (48th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.95β · 25% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.